Comprehensive review of reports of menstrual irregularities associated with isotretinoin
In 1982, oral isotretinoin was first licensed as a treatment option for severe recalcitrant cystic acne in the United States. Since its introduction into the pharmaceutical market, several instances of amenorrhea in women of child-bearing age taking isotretinoin have been reported. In each documente...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-12-01
|
| Series: | International Journal of Women's Dermatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352647520301167 |